Results 291 to 300 of about 3,775,993 (302)

The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs

Chemical Reviews, 2016
Timothy C Johnstone, Kogularamanan Suntharalingam, Stephen J Lippard   +2 more
exaly  

Rheumatic syndromes caused by antirheumatic drugs

Baillière's Clinical Rheumatology, 1991
Béla Szebenyi, P.J. Rooney, Géza P. Bálint, Petros Petrou   +3 more
openaire   +3 more sources

Combining epigenetic drugs with other therapies for solid tumours — past lessons and future promise

Nature Reviews Clinical Oncology, 2019
Daphné Morel, Daniel Jeffery, Sandrine Aspeslagh   +2 more
exaly  

Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis

Annals of the Rheumatic Diseases, 2016
G. Ozen, S. Pedro, M. Holmqvist, Michael Avery, F. Wolfe, K. Michaud   +5 more
semanticscholar   +1 more source

Classification of antirheumatic drugs. A new proposal

Arthritis & Rheumatism, 1992
David Scott, David Scott, John Edmonds, John Edmonds, Harold E. Paulus   +4 more
openaire   +3 more sources

Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?

Nature Reviews Clinical Oncology, 2016
Adi J Klil-Drori, Laurent Azoulay, Michael N Pollak   +2 more
exaly  

INDOMETHACIN, REMARKABLE ANTIRHEUMATIC DRUG

Medical Journal of Australia, 1964
openaire   +3 more sources

Medical marijuana for cancer

Ca-A Cancer Journal for Clinicians, 2015
exaly  

Cancer Anorexia-Cachexia Syndrome: Current Issues in Research and Management

Ca-A Cancer Journal for Clinicians, 2002
exaly  

New approaches to antirheumatic drugs

Trends in Pharmacological Sciences, 1985
openaire   +2 more sources